Skip to content

Clinical trials

Phase 2 Dysbiosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dysbiosis Phase: Phase 2 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20221
20231
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Completed2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Center Eugene Marquis1
Industrial Microbiology LLP1
Jean-Pierre Routy1
Johns Hopkins University1
Universidade Federal Fluminense1
University Hospital of North Norway1
Vanderbilt University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dysbiosis7
Anemia, Iron-Deficiency1
Arthritis1
Axial Spondyloarthritis1
Carcinoma, Hepatocellular1
Cardiovascular Diseases1
Congenital Microtia1
HIV Infections1
Inflammation1
Irritable Bowel Syndrome1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.